In half a day, the main funds increased their positions in the pharmaceutical and biotechnology sector while selling off the electronics sector36Kr·Nov 13, 2025 at 09:56 PM6001570.00%000547+3.05%
ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10%Zhitong·Oct 30, 2025 at 06:08 AM002317+4.92%
ZHONGSHENGYAOYE: Subsidiary receives approval notice for the listing application of polyvinyl alcohol chemical raw materialsZhitong·Oct 27, 2025 at 05:09 AM002317+4.92%
ZHONGSHENGYAOYE's subsidiary has obtained ethical approval for the Phase III clinical trial of the innovative drug Anglatide granulesZhitong·Sep 29, 2025 at 06:05 AM002317+4.92%
ZHONGSHENGYAOYE released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, a year-on-year increase of 114.96%Zhitong·Aug 28, 2025 at 11:21 AM002317+4.92%
ZHONGSHENGYAOYE: The first participant has been enrolled in the Phase III clinical trial of RAY1225 injection for glycemic reductionZhitong·Aug 27, 2025 at 04:46 AM002317+4.92%
Huaxin Securities: New drug overseas licensing revenue is gradually confirmed, and the pharmaceutical industry ecosystem continues to improveZhitong·Aug 24, 2025 at 10:42 PM603259+2.35%02359+1.90%
The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suitZhitong·Aug 24, 2025 at 08:52 PM301331+3.88%002873+2.54%
Cathay Securities and Haitong Securities: The first year of commercialization for domestic innovative weight loss drugs, there are still many catalysts for related companies in the futureZhitong·Aug 4, 2025 at 03:36 AM03933-2.51%02105+12.04%
A-shares closing: The ChiNext Index surged 1.86%, with pharmaceutical stocks experiencing a widespread breakoutWallstreetcn·Jul 29, 2025 at 02:02 AM002370+1.68%603773+2.81%
The concept of innovative drugs continues to be active, CISEN once again hits the daily limitZhitong·Jul 28, 2025 at 08:59 PM603367+1.73%688513+0.81%
ZHONGSHENGYAOYE: The active pharmaceutical ingredient of aluminum chlorobenzoate has received approval for the listing application of chemical raw materialsZhitong·Jul 25, 2025 at 04:58 AM002317+4.92%
ZHONGSHENGYAOYE: It is expected that the net profit in the first half of 2025 will increase by 94.49%-140.25% year-on-yearZhitong·Jul 14, 2025 at 06:34 AM002317+4.92%
ZHONGSHENGYAOYE has obtained the drug registration certificates for Cyclosporine Eye Drops (III) and Compound Tropicamide Eye DropsZhitong·Jul 1, 2025 at 06:18 AM002317+4.92%
Ping An Securities: The future market prospects of GLP-1RA are broad, and it is recommended to pay attention to investment opportunities in the fat reduction and muscle gain trackZhitong·Jun 24, 2025 at 03:05 AM02105+12.04%002317+4.92%
